Dual HER/VEGF receptor targeting inhibits in vivo ovarian cancer tumor growth

Ovarian cancer mortality ranks highest among all gynecological cancers with growth factor pathways playing an integral role in tumorigenesis, metastatic dissemination and therapeutic resistance. The human epidermal growth factor receptor (HER) and vascular endothelial growth factor receptor (VEGFR)...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Becker, Marc A., Farzan, Thahir, Harrington, Sean C., Krempski, James W., Weroha, S. John, Hou, Xiaonan, Kalli, Kimberly R., Wong, Tai W., Haluska, Paul
Format: Artigo
Idioma:Inglês
Publicat: 2013
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3880137/
https://ncbi.nlm.nih.gov/pubmed/24130056
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-13-0547
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars